What’s Next For bluebird bio After The U.S. FDA Lifts Hold On Clinical Trials [Forbes]
bluebird bio, Inc. (BLUE)
Last bluebird bio, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.bluebirdbio.com/investor-overview
Company Research
Source: Forbes
BRAZIL - 2021/02/18: In this photo illustration a Bluebird Bio logo seen displayed on a smartphone.... [+](Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)We believe that the stock price ofbluebird bioThis underperformance can be attributed to the company’s announcement of placing its clinical trials of LentiGlobin gene therapy for sickle cell disease on a temporary suspension earlier this year. This decision was taken after a patient who was treated for SDC was diagnosed with acute myeloid leukemia. However, yesterday, the U.S. FDA allowed bluebird bio to continue its trials, and this will bode well for BLUE stock going forward.Now that the stock has seen a large drop (down 55% in the last one year) despite revenue rising 347% y-o-y over the last four quarters, we believe BLUE stock is likely to see higher levels in the near term. Our dashboard ‘Buy Or Fear bluebird bio StockStock PricesTrefisLooking at a longer time period, BLUE stock is down 68% from
Show less
Read more
Impact Snapshot
Event Time:
BLUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLUE alerts
High impacting bluebird bio, Inc. news events
Weekly update
A roundup of the hottest topics
BLUE
News
- Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors – Contact Levi & KorsinskyAccesswire
- BLUE INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUEGlobeNewswire
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the FirmPR Newswire
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUEAccesswire
- Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUEAccesswire
BLUE
Earnings
- 11/7/23 - Beat
BLUE
Sec Filings
- 4/16/24 - Form 8-K
- 4/10/24 - Form SC
- 3/26/24 - Form 8-K
- BLUE's page on the SEC website